Author

Felipe Moura Maia Pinheiro

Observed names: F M Maia Pinheiro, F Moura Maia Pinheiro, Pinheiro, Felipe M M, Pinheiro, Felipe Moura Maia

Institution: Universidade de Cuiabá

Observed institutions: University of Rome Tor Vergata, Faculdade de Medicina de São José do Rio Preto, University of Miami, Universidade de São Paulo, Saint Camillus International University of Health and Medical Sciences, Centro Universitário de Várzea Grande, Universal Scientific Education and Research Network, Universidade de Cuiabá, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Hospital de Base

ORCID: 0000-0002-9627-8407

Observed ORCID: 0000-0002-9627-8407

OpenAlex ID: A5002887224

Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3

2016 · Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, et al. · Endocrinology Diabetes and Metabolism Case Reports · 36

Dipeptidyl peptidase-4 inhibitors (DPP-4i) combined with vitamin D3: An exploration to treat new-onset type 1 diabetes mellitus and latent autoimmune diabetes in adults in the future

2018 · Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, et al. · International Immunopharmacology · 30

Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes

2021 · Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, et al. · International Immunopharmacology · 28

The first report of leukocytoclastic vasculitis induced by once-weekly subcutaneous semaglutide

2024 · Marcelo Maia Pinheiro, Luciana Gasques de Souza, et al. · Current Medical Research and Opinion · 24

How to manage intolerance to dopamine agonist in patients with prolactinoma

2023 · Matheo Augusto Morandi Stumpf, Felipe Moura Maia Pinheiro, et al. · Pituitary · 23

Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study

2023 · Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, et al. · Archives of Endocrinology and Metabolism · 17

Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways

2024 · Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, et al. · Metabolism and Target Organ Damage · 9

Improvement of pure sensory mononeuritis multiplex and IgG1 deficiency with sitagliptin plus Vitamin D3.

2020 · M Maia Pinheiro, F Moura Maia Pinheiro, et al. · PubMed · 7

36-month follow-up of a pure sensory mononeuritis multiplex and IgG1 deficiency improved after treatment with sitagliptin and Vitamin D3.

2021 · M Maia Pinheiro, F M Maia Pinheiro, et al. · PubMed · 5

Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes

2025 · Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, et al. · Medical Sciences · 4

Type 1 diabetes prevention and treatment: Time to think outside the box

2023 · Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro · Journal of Diabetes · 3

Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005–1013

2023 · Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro · Diabetes Care · 2

Comment on Narsale et al. Th2 cell clonal expansion at diagnosis in human type 1 diabetes. Clin Immunol. 2023 Oct 29

2023 · Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, et al. · Clinical Immunology

Vitamin D3 in the Type 1 Diabetes and Latent Autoimmune Diabetes in Adults, Its Use for Prevention and Treatment

2019 · Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro · Elsevier eBooks

2019 · Jamiu Busari Ahmad, Haji Akber Aisa, et al. · Elsevier eBooks

Works count: 17

Citation count: 188

H-index: 7

I10-index: 6